TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

NCT07489755 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myelogenous Leukemia
Chronic Myelogenous Leukemia - Chronic Phase

Interventions

DRUG: TGRX-678
DRUG: TKI

Sponsor

Shenzhen TargetRx Co., Ltd.